New Frontiers in Treatment of Lung Cancer
Both small cell (SCLC) and non-small cell lung cancer (NSCLC) have had significant developments in treatment of both locoregional as well as distant disease. We will review recent attempts to improve delivery, better personalize treatment, minimize toxicity, and incorporate novel modalities (such as immunotherapy and Tumor Treating Fields) for the treatment of the various stages of lung cancer.
Reference:
30-04
Session:
Session 30: Radiotherapy of Cancer
Presenter/s:
Charles Hsu
Presentation type:
Invited Speaker Presentation
Room:
Emerald Ballroom
Chair/s:
Baldassarre Stea, Roy E. Abendroth
Date:
Saturday, April 22, 2017
Time:
14:35 - 14:55
Session times:
13:35 - 15:05